TINAVI(SH:688277) Xin Lang Cai Jing·2025-11-24 02:18Core Viewpoint - Tianzhihang's stock price has experienced a decline recently, despite a significant increase in its stock price year-to-date, indicating potential volatility in the market [1][2]. Company Overview - Tianzhihang Medical Technology Co., Ltd. specializes in the research, production, sales, and service of orthopedic surgical navigation robots, with a revenue composition of 58.31% from navigation robots, 23.86% from supporting equipment and consumables, 16.49% from technical services, and 1.31% from other sources [1]. - The company was established on October 22, 2010, and went public on July 7, 2020 [1]. Financial Performance - For the period from January to September 2025, Tianzhihang reported a revenue of 187 million yuan, representing a year-on-year growth of 103.51%. However, the net profit attributable to shareholders was -114 million yuan, a decrease of 49.73% compared to the previous year [2]. - The stock price has increased by 55.26% year-to-date, but has seen declines of 8.76% over the last five trading days, 12.22% over the last twenty days, and 22.18% over the last sixty days [1]. Shareholder and Market Activity - As of September 30, 2025, the number of shareholders increased by 12.31% to 17,300, with an average of 26,094 shares held per shareholder, a decrease of 10.96% [2]. - The company has appeared on the "Dragon and Tiger List" once this year, with the most recent appearance on February 17, where it recorded a net purchase of 26.27 million yuan [1]. Market Position - Tianzhihang is categorized under the pharmaceutical and biological industry, specifically in medical devices, and is associated with concepts such as robotics, specialized innovation, and medical equipment [2].